Added benefit of dapagliflozin is not proven
Manufacturer's dossier did not contain suitable data for any therapeutic indication Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes…
You must be logged in to post a comment.